Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Blood

• Publication date

  2000-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V96.8.2655PMID 11023495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein Kinases and Phosphatases: The Yin and Yang of Protein Phosphorylation and Signaling Review

  2004cited by this paper
• The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia.

  2000cited by this paper
• The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis.

  1999cited by this paper
• Stromal Cell-derived Factor-1α Associates with Heparan Sulfates through the First β-Strand of the Chemokine*

  1999cited by this paper
• The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment.

  1999cited by this paper
• A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution.

  1999cited by this paper
• Perspectives: signal transduction. Cell survival demands some Rsk.

  1999cited by this paper
• Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms.

  1999cited by this paper
• Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)

  1999cited by this paper
• Regulation of cell survival during B lymphopoiesis: suppressed apoptosis of pro‐B cells in P53‐deficient mouse bone marrow

  1999cited by this paper
• Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.

  1999cited by this paper
• Survival of human leukaemic B‐cell precursors is supported by stromal cells and cytokines: association with the expression of bcl‐2 protein

  1999cited by this paper
• Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin.

  1999cited by this paper
• Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells.

  1998cited by this paper
• B Lymphocyte Chemotaxis Regulated in Association with Microanatomic Localization, Differentiation State, and B Cell Receptor Engagement

  1998cited by this paper
• Associations between TGF‐β1 receptors in human bone marrow stromal cells

  1998cited by this paper
• Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.

  1998cited by this paper
• Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells*

  1998cited by this paper
• Signaling by integrin receptors

  1998cited by this paper
• Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.

  1998cited by this paper
• The α-Chemokine, Stromal Cell-derived Factor-1α, Binds to the Transmembrane G-protein-coupled CXCR-4 Receptor and Activates Multiple Signal Transduction Pathways*

  1998cited by this paper
• Stromal cell-derived factor-1 alpha and stem cell factor/kit ligand share signaling pathways in hemopoietic progenitors: a potential mechanism for cooperative induction of chemotaxis.

  1998cited by this paper
• The cellular biology of B-cell chronic lymphocytic leukemia.

  1998cited by this paper
• Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.

  1998cited by this paper
• Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

  1998cited by this paper
• The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

  1998cited by this paper
• Induction of an apoptotic program in cell-free extracts by 2-chloro-2'-deoxyadenosine 5'-triphosphate and cytochrome c.

  1998cited by this paper
• Dendritic cells in the T‐cell areas of lymphoid organs

  1997cited by this paper
• Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

  1996cited by this paper
• Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX.

  1996cited by this paper
• Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts

  1996cited by this paper
• Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro

  1996cited by this paper
• A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

  1996cited by this paper
• Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.

  1995cited by this paper
• Positive and negative selection events during B lymphopoiesis.

  1995cited by this paper
• Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene.

  1995cited by this paper
• Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

  1995cited by this paper
• Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo

  1995cited by this paper
• Hematology: Basic Principles and Practice

  1995cited by this paper
• Establishment and characterization of nurse cell-like clones from human skin. Nurse cell-like clones can stimulate autologous mixed lymphocyte reaction.

  1994cited by this paper
• Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells.

  1994cited by this paper
• Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells

  1994cited by this paper
• Molecular cloning and structure of a pre-B-cell growth-stimulating factor.

  1994cited by this paper
• Apoptosis and Macrophage‐Mediated Cell Deletion in the Regulation of B Lymphopoiesis in Mouse Bone Marrow

  1994cited by this paper
• bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.

  1993cited by this paper
• Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl‐2 induction

  1993cited by this paper
• Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture

  1992cited by this paper
• Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method.

  1992cited by this paper
• Human B-lymphopoiesis is supported by bone marrow-derived stromal cells.

  1991cited by this paper
• Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1.

  1991cited by this paper
• Regulation of hemopoiesis by bone marrow stromal cells and their products.

  1990cited by this paper
• Microenvironmental organization and stromal cell associations of B lymphocyte precursor cells in mouse bone marrow

  1990cited by this paper
• Spontaneous programmed death (apoptosis) of B‐chronic lymphocytic leukaemia cells following their culture in vitro

  1989cited by this paper
• Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis

  1988cited by this paper
• Relationships between B‐lineage lymphocytes and stromal cells in long‐term bone marrow cultures

  1987cited by this paper
• Patterns of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well differentiated) non‐hodgkin's lymphoma. Its clinical significance in relation to their differential diagnosis and prognosis

  1984cited by this paper
• Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data.

  1984cited by this paper
• The glyceraldehyde 3 phosphate dehydrogenase gene family: structure of a human cDNA and of an X chromosome linked pseudogene; amazing complexity of the gene family in mouse.

  1984cited by this paper
• Long-term culture of B lymphocytes and their precursors from murine bone marrow.

  1982cited by this paper
• Thymic nurse cells. Lymphoepithelial cell complexes in murine thymuses: morphological and serological characterization

  1980cited by this paper
• Symbiotic culture of mouse leukaemias: Regulation of cell interaction by an activity of serum

  1980cited by this paper

• CaMKK2 Identifies Biologically Aggressive Chronic Lymphocytic Leukemia and Regulates Leukemic Survival and Nurse-Like Cell Support

  2026cites this paper
• Trogocytosis-mediated transfer of FOLR2 from nurse-like cells to CLL cells is associated with their activation and proliferation

  2026cites this paper
• “Monocytes in B-Cell Malignancies: Their Role in Disease Progression and Therapy Resistance”

  2025cites this paper
• G-protein coupled receptor kinase-2 regulates the migration of chronic lymphocytic leukaemia cells to sphingosine-1 phosphate in vitro and their trafficking in vivo

  2025cites this paper
• Functional differences between CLL‐ and ALL‐derived CAR T cells in a 3D tumor microenvironment highlight CXCR4 and IL‐10 as potential modulatory targets

  2025cites this paper
• Tumor microenvironment as a novel therapeutic target for lymphoid leukemias

  2025cites this paper
• Comparative analysis of macrophage feeder systems reveals distinct behaviors and key transcriptional shifts in chronic lymphocytic leukemia cells via coculture

  2025cites this paper
• Targeting the Immune Microenvironment in Chronic Lymphocytic Leukemia: An Evolving Therapeutic Strategy

  2025cites this paper
• The Role of Tumor Microenvironment and Targeted Therapy in Chronic Lymphocytic Leukemia

  2025cites this paper
• Increased STAT3 Phosphorylation in CD4+ T-Cells of Treated Patients with Chronic Lymphocytic Leukemia and Changes in Circulating Regulatory T-Cell Subsets Relative to Tumor Mass Distribution Value and Disease Duration

  2025cites this paper
• Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse‐like cells via an RNA‐dependent mechanism

  2025cites this paper
• CLL cell-derived exosomes alter the immune and hematopoietic systems

  2025cites this paper
• Reduced CSF1R expression in myeloid cells has limited impact on chronic lymphocytic leukemia progression

  2025cites this paper
• Immunotherapy in Chronic Lymphocytic Leukemia.

  2025cites this paper
• Wnt5a induces ROR1 dependent NF-κB activation to enhance MMP-9 expression and invasiveness in chronic lymphocytic leukemia

  2025cites this paper
• B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice

  2024cites this paper
• Potential New Therapies “ROS-Based” in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis

  2024cites this paper
• Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy

  2024cites this paper
• Lessons learned from the Eµ-TCL1 mouse model of CLL.

  2024cites this paper
• NOD2 activation enhances macrophage Fcγ receptor function and may increase the efficacy of antibody therapy

  2024cites this paper
• Tumor Cell Survival Factors and Angiogenesis in Chronic Lymphocytic Leukemia: How Hot Is the Link?

  2024cites this paper
• CD38/NAD+ glycohydrolase and associated antigens in chronic lymphocytic leukaemia: from interconnected signalling pathways to therapeutic strategies.

  2024cites this paper
• Are we ready to integrate 3D culture systems in acute myeloid leukemia and bone marrow microenvironment research?

  2024cites this paper
• The survival grip–how cell adhesion promotes tumor maintenance within the microenvironment

  2024cites this paper
• Molecular aspects of pathogenesis of chronic lymphocytic leukemia

  2024cites this paper
• Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo

  2024cites this paper
• JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLL

  2024cites this paper
• Advancing CAR T-cell therapy for chronic lymphocytic leukemia: exploring resistance mechanisms and the innovative strategies to overcome them

  2024cites this paper
• T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.

  2024cites this paper
• Cross‐talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review

  2024cites this paper
• Targeting the tumor microenvironment for treating double refractory chronic lymphocytic leukemia.

  2024cites this paper
• Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemia.

  2024cites this paper
• Transforming CLL management with immunotherapy: Investigating the potential of CAR T-cells and bispecific antibodies.

  2024cites this paper
• Macrophages are activated toward phagocytic lymphoma cell clearance by pentose phosphate pathway inhibition

  2024cites this paper
• Electron transport chain and mTOR inhibition synergistically decrease CD40 signaling and counteract venetoclax resistance in chronic lymphocytic leukemia

  2023cites this paper
• The Dual Role of Mesenchymal Stem Cells in Cancer Pathophysiology: Pro-Tumorigenic Effects versus Therapeutic Potential

  2023cites this paper
• Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment

  2023cites this paper
• Macrophage-Based Therapeutic Strategies in Hematologic Malignancies

  2023cites this paper
• Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia

  2023cites this paper
• New insights in application of mesenchymal stem cells therapy in tumor microenvironment: pros and cons

  2023cites this paper
• Role of the tumor microenvironment in CLL pathogenesis.

  2023cites this paper
• CCL3 as Possible Negative Prognostic Factor in Chronic Lymphocytic Leukemia

  2023cites this paper
• Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia

  2023cites this paper
• Pentose Phosphate Pathway Inhibition activates Macrophages towards phagocytic Lymphoma Cell Clearance

  2023cites this paper
• SOHO State of the Art Updates and Next Questions | Infections in Chronic Lymphocytic Leukemia Patients: Risks and Management.

  2023cites this paper
• NF-kB and the CLL microenvironment

  2023cites this paper
• Active Hexose-Correlated Compound Shows Direct and Indirect Effects against Chronic Lymphocytic Leukemia

  2023influential citation
• The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia

  2023influential citation
• Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia

  2023cites this paper
• Unraveling the Bone Tissue Microenvironment in Chronic Lymphocytic Leukemia

  2023cites this paper
• Characterization of metabolic alterations of Chronic Lymphocytic Leukemia in the lymph node microenvironment.

  2022cites this paper
• Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia

  2022cites this paper
• JAK–STAT signalling shapes the NF‐κB response in CLL towards venetoclax sensitivity or resistance via Bcl‐XL

  2022cites this paper
• A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation

  2022cites this paper
• Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia

  2022cites this paper
• Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential

  2022cites this paper
• Ex vivo culture of malignant primary B cells

  2022influential citation
• The Yin-Yang of myeloid cells in the leukemic microenvironment: Immunological role and clinical implications

  2022cites this paper
• Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies

  2022cites this paper
• CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings

  2022cites this paper
• Biology and Treatment of Richter Transformation

  2022cites this paper
• Disruption of Nurse-like Cell Differentiation as a Therapeutic Strategy for Chronic Lymphocytic Leukemia

  2022cites this paper
• Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice

  2022cites this paper
• Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures

  2022cites this paper
• Aberrantly expressed Wnt5a in nurse-like cells drives resistance to Venetoclax in chronic lymphocytic leukemia

  2022cites this paper
• Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL

  2022cites this paper
• CD160 receptor in CLL: Current state and future avenues

  2022cites this paper
• The CXCL12 Crossroads in Cancer Stem Cells and Their Niche

  2021cites this paper
• Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells: A Mutualistic Crosstalk inside Tissue Microenvironments

  2021cites this paper
• Protein kinase C‐β‐dependent changes in the glucose metabolism of bone marrow stromal cells of chronic lymphocytic leukemia

  2021cites this paper
• Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines

  2021cites this paper
• Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?

  2021cites this paper
• Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL

  2021cites this paper
• Quercetin shortened survival of radio-resistant B-1 cells in vitro and in vivo by restoring miR15a/16 expression

  2021cites this paper
• Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells

  2021cites this paper
• SIRPα Suppresses Response to Therapeutic Antibodies by Nurse Like Cells From Chronic Lymphocytic Leukemia Patients

  2021cites this paper
• IL-10 Rescues CLL Survival through Repolarization of Inflammatory Nurse-like Cells

  2021influential citation
• A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation.

  2021cites this paper
• O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers

  2021influential citation
• Bone Marrow Lymphoid Niche Adaptation to Mature B Cell Neoplasms

  2021cites this paper
• Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target

  2021cites this paper
• Brief Report

  2021cites this paper
• Physiopathologie de la leucémie lymphoïde chronique

  2021cites this paper
• Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance

  2021cites this paper
• An agent-based model of monocyte differentiation into tumour-associated macrophages in chronic lymphocytic leukemia

  2021cites this paper
• Mining the Microenvironment for Therapeutic Targets in Chronic Lymphocytic Leukemia

  2021cites this paper
• CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness

  2021cites this paper
• Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome

  2021cites this paper
• BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1

  2021cites this paper
• Notch in Human Cancers—A Complex Tale

  2021cites this paper
• The Role of Tumor-Associated Macrophages in Hematologic Malignancies

  2021influential citation
• Prognostic Value of Tie2-Expressing Monocytes in Chronic Lymphocytic Leukemia Patients

  2021cites this paper
• Migration and Adhesion of B-Lymphocytes to Specific Microenvironments in Mantle Cell Lymphoma: Interplay between Signaling Pathways and the Epigenetic Landscape

  2021cites this paper
• Downregulation of CCL22 and Mutation of NOTCH1 in Tongue Squamous Cell Carcinoma Decreases Th2 Cell Recruitment and Expression to Predict Poor Clinical Outcomes

  2021cites this paper
• Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL

  2021cites this paper
• Exploring the Pathways to Chronic Lymphocytic Leukemia.

  2021cites this paper
• FoxO1-GAB1 Axis Regulates Homing Capacity and Tonic AKT Activity in Chronic Lymphocytic Leukemia.

  2021cites this paper
• Targeting the tumor microenvironment in chronic lymphocytic leukemia

  2021cites this paper
• Leukaemia: a model metastatic disease

  2021cites this paper
• Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity

  2021cites this paper